No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| KNSLKinsale Capital Group, Inc. | 9.08B | 390.33 | 21.95 | 29.65% | 26.3% | 25.42% | 10.49% | 0.12 |
| RLIRLI Corp. | 5.45B | 59.38 | 15.88 | 17.09% | 19.02% | 18.84% | 10.19% | 0.07 |
| MKLMarkel Corporation | 26.73B | 2119.42 | 10.63 | 6.6% | 12.73% | 11.18% | 8.75% | 0.25 |
| GBLIGlobal Indemnity Group, LLC | 305.17M | 28.98 | 9.29 | -16.46% | 6.31% | 3.96% | 12.73% | 0.02 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 796.47M | 817.85M | 800.8M | 820.36M | 1.01B | 987.68M | 1.18B | 1.7B | 1.51B | 1.77B |
| Revenue Growth % | 0.02% | 0.03% | -0.02% | 0.02% | 0.23% | -0.02% | 0.2% | 0.43% | -0.11% | 0.17% |
| Medical Costs & Claims | 486.01M | 544.21M | 605.29M | 640.94M | 651.15M | 679.92M | 723.95M | 966.22M | 1.12B | 1.32B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 310.46M | 273.64M | 195.51M | 179.43M | 355.47M | 307.76M | 459.6M | 731.77M | 390.87M | 454.63M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.05% | -0.12% | -0.29% | -0.08% | 0.98% | -0.13% | 0.49% | 0.59% | -0.47% | 0.16% |
| Operating Expenses | 113.78M | 116.56M | 110.92M | 111.84M | 122.74M | 117.92M | 115.28M | 11.09M | 13.61M | 27.08M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 5.41M | 6.43M | 6.94M | 7.04M | 8.16M | 7.43M | 7.39M | 7.98M | 8.54M | 7.66M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 196.68M | 157.08M | 84.59M | 67.58M | 232.73M | 189.84M | 344.32M | 720.68M | 377.26M | 427.55M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.04% | -0.2% | -0.46% | -0.2% | 2.44% | -0.18% | 0.81% | 1.09% | -0.48% | 0.13% |
| EBITDA | 202.09M | 163.51M | 91.53M | 74.62M | 240.9M | 197.27M | 351.71M | 728.66M | 385.81M | 435.21M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 7.43M | 7.43M | 7.43M | 7.44M | 7.59M | 7.6M | 7.68M | 8.05M | 7.3M | 6.33M |
| Non-Operating Income | -7.43M | -7.43M | -7.43M | -7.44M | -7.59M | -7.6M | -7.68M | -8.05M | -7.3M | -6.33M |
| Pretax Income | 196.68M | 157.08M | 84.59M | 67.58M | 232.73M | 189.84M | 344.32M | 720.68M | 377.26M | 427.55M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 59.14M | 42.16M | -20.44M | 3.4M | 41.09M | 32.75M | 64.97M | 137.27M | 72.65M | 81.77M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 137.54M | 114.92M | 105.03M | 64.18M | 191.64M | 157.09M | 279.35M | 583.41M | 304.61M | 345.78M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.02% | -0.16% | -0.09% | -0.39% | 1.99% | -0.18% | 0.78% | 1.09% | -0.48% | 0.14% |
| EPS (Diluted) | 1.56 | 1.30 | 1.18 | 0.72 | 2.12 | 1.73 | 3.06 | 6.37 | 3.31 | 3.74 |
| EPS Growth % | 0.01% | -0.17% | -0.09% | -0.39% | 1.97% | -0.18% | 0.77% | 1.08% | -0.48% | 0.13% |
| EPS (Basic) | 1.56 | 1.31 | 1.19 | 0.72 | 2.14 | 1.75 | 3.09 | 6.43 | 3.34 | 3.78 |
| Diluted Shares Outstanding | 88.26M | 88.86M | 89M | 89.67M | 90.51M | 90.75M | 91.42M | 91.59M | 92.15M | 92.45M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.74B | 2.78B | 2.95B | 3.11B | 3.55B | 3.94B | 4.51B | 4.77B | 5.18B | 5.63B |
| Asset Growth % | -0.01% | 0.02% | 0.06% | 0.05% | 0.14% | 0.11% | 0.14% | 0.06% | 0.09% | 0.09% |
| Total Investment Assets | 1.98B | 2.05B | 2.16B | 2.2B | 2.62B | 2.9B | 3.25B | 3.31B | 3.7B | 74.92M |
| Long-Term Investments | 1.98B | 2.05B | 2.16B | 2.2B | 2.55B | 2.85B | 3.19B | 3.26B | 3.64B | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 1.98B | 2.2B | 2.41B | 2.7B | 2.99B | 74.92M |
| Total Current Assets | 1.95B | 2.02B | 2.14B | 2.19B | 0 | 0 | 0 | 0 | 0 | 114.7M |
| Cash & Equivalents | 17.34M | 23.28M | 34.25M | 41.69M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M | 39.79M |
| Receivables | 0 | 1000K | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 184.33M | 0 | 0 | -2.67B | -2.99B | -3.4B | -3.79B | -4.12B | -230.53M |
| Goodwill & Intangibles | 71.29M | 64.37M | 59.3M | 54.53M | 54.13M | 53.72M | 53.56M | 53.56M | 53.56M | 53.56M |
| Goodwill | 58.5M | 51.27M | 49.66M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M |
| Intangible Assets | 12.8M | 13.1M | 9.64M | 8.47M | 8.06M | 7.66M | 7.5M | 7.5M | 7.5M | 7.5M |
| PP&E (Net) | 47.1M | 54.61M | 55.85M | 54.69M | 53.12M | 51.41M | 52.16M | 49.57M | 46.72M | 43.17M |
| Other Assets | -1.41B | -1.47B | -1.53B | -1.42B | -2.65B | -2.95B | -3.3B | -3.36B | -3.74B | 0 |
| Total Liabilities | 1.91B | 1.95B | 2.09B | 2.3B | 2.55B | 2.8B | 3.28B | 3.59B | 3.77B | 4.11B |
| Total Debt | 149.67M | 148.74M | 148.93M | 149.12M | 149.3M | 149.49M | 199.68M | 399.73M | 200M | 100M |
| Net Debt | 132.32M | 125.46M | 114.68M | 107.42M | 103.1M | 87.27M | 110.87M | 376.91M | 163.58M | 60.21M |
| Long-Term Debt | 148.55M | 148.74M | 148.93M | 149.12M | 149.3M | 149.49M | 199.68M | 199.86M | 100M | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 199.86M | 100M | 100M |
| Total Current Liabilities | 1.76B | 1.81B | 1.94B | 2.15B | 0 | 0 | 0 | 0 | 0 | 145.43M |
| Accounts Payable | 37.56M | 17.93M | 21.62M | 22.59M | 25.69M | 42.27M | 42.85M | 61.1M | 71.51M | 44.68M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -93.3M | -69.92M | -74.47M | -67.72M | -92.32M | -118.19M | -141.13M | -355.83M | -284.14M | -124.24M |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | -206.03M | -229.72M | -283.19M | -199.86M | -100M | 4.01B |
| Total Equity | 823.47M | 823.57M | 853.6M | 806.84M | 995.39M | 1.14B | 1.23B | 1.18B | 1.41B | 1.52B |
| Equity Growth % | -0.03% | 0% | 0.04% | -0.05% | 0.23% | 0.14% | 0.08% | -0.04% | 0.2% | 0.08% |
| Shareholders Equity | 823.47M | 823.57M | 853.6M | 806.84M | 995.39M | 1.14B | 1.23B | 1.18B | 1.41B | 1.52B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 804.88M | 797.31M | 788.52M | 908.08M | 1.01B | 1.08B | 1.23B | 1.45B | 1.61B | 1.72B |
| Common Stock | 66.47M | 66.88M | 67.08M | 674K | 678K | 681K | 682K | 684K | 1.37M | 1.38M |
| Accumulated OCI | 123.77M | 122.61M | 157.92M | -14.57M | 52.47M | 108.71M | 49.83M | -229.08M | -166.3M | -173.72M |
| Return on Equity (ROE) | 0.16% | 0.14% | 0.13% | 0.08% | 0.21% | 0.15% | 0.24% | 0.48% | 0.24% | 0.24% |
| Return on Assets (ROA) | 0.05% | 0.04% | 0.04% | 0.02% | 0.06% | 0.04% | 0.07% | 0.13% | 0.06% | 0.06% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.18x | 0.18x | 0.17x | 0.18x | 0.15x | 0.13x | 0.16x | 0.34x | 0.14x | 0.07x |
| Book Value per Share | 9.33 | 9.27 | 9.59 | 9.00 | 11.00 | 12.52 | 13.45 | 12.85 | 15.34 | 16.46 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 152.59M | 174.46M | 197.53M | 217.1M | 276.92M | 263.26M | 384.9M | 250.45M | 464.26M | 560.22M |
| Operating CF Growth % | 0.24% | 0.14% | 0.13% | 0.1% | 0.28% | -0.05% | 0.46% | -0.35% | 0.85% | 0.21% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 137.54M | 114.92M | 105.03M | 64.18M | 191.64M | 157.09M | 279.35M | 583.41M | 304.61M | 345.78M |
| Depreciation & Amortization | 5.41M | 6.43M | 6.94M | 7.04M | 8.16M | 7.43M | 7.39M | 7.98M | 8.54M | 7.66M |
| Stock-Based Compensation | 4.1M | 4.1M | 4.8M | 5.5M | 6M | 5.4M | 6M | 9M | 9M | 8M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -16.46M | -6.17M | -25.16M | 60.11M | -27.09M | -8.4M | -41.37M | -458.42M | 31.27M | 10.87M |
| Working Capital Changes | 22M | 55.18M | 105.91M | 80.27M | 98.2M | 101.74M | 133.52M | 108.47M | 110.83M | 187.91M |
| Cash from Investing | -60.6M | -53.62M | -81.21M | -134.21M | -184.75M | -167.99M | -274.83M | 48.88M | -211.8M | -318.87M |
| Capital Expenditures | -10.04M | -16.16M | -9.24M | -6.09M | -6.96M | -5.77M | -8.31M | -5.89M | -5.91M | 0 |
| Acquisitions | 5.79M | -850K | 408K | 167K | 0 | -4.53M | -8.98M | 682.85M | 14.28M | 0 |
| Purchase of Investments | -705.33M | -593.4M | -456.41M | -843.17M | -617.66M | -596.23M | -874.53M | -2.13B | -816.42M | -909.85M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Other Investing | -4.43M | -6.03M | -16.92M | -15.36M | -20.25M | -8.52M | -3.82M | -2.67M | -24.23M | 590.98M |
| Cash from Financing | -111.53M | -113.65M | -110.31M | -77.02M | -76.1M | -79.26M | -83.49M | -365.31M | -238.85M | -237.98M |
| Dividends Paid | -119.58M | -122.49M | -113.81M | -83.1M | -85.59M | -87.91M | -135.33M | -364.85M | -140.09M | -235.66M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 8.05M | 8.84M | 3.5M | 6.08M | 9.49M | 8.65M | 1.84M | -465K | 1.25M | -2.33M |
| Debt Issuance (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | -1000K | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -19.54M | 7.19M | 6M | 5.87M | 16.06M | 16.01M | 26.59M | -65.99M | 13.61M | 3.37M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 30.62M | 11.08M | 18.27M | 24.27M | 30.14M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M |
| Cash at End | 11.08M | 18.27M | 24.27M | 30.14M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M | 39.79M |
| Free Cash Flow | 142.55M | 158.31M | 188.29M | 211.01M | 269.96M | 257.49M | 376.6M | 244.56M | 458.34M | 555.51M |
| FCF Growth % | 0.23% | 0.11% | 0.19% | 0.12% | 0.28% | -0.05% | 0.46% | -0.35% | 0.87% | 0.21% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 1.62 | 1.78 | 2.12 | 2.35 | 2.98 | 2.84 | 4.12 | 2.67 | 4.97 | 6.01 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 75.31% | 80.79% | 89.44% | 91.76% | 76.88% | 80.78% | 70.91% | 57.56% | 75.05% | 75.85% |
| Medical Cost Ratio | 61.02% | 66.54% | 75.59% | 78.13% | 64.69% | 68.84% | 61.17% | 56.9% | 74.15% | 74.32% |
| Return on Equity (ROE) | 16.49% | 13.95% | 12.52% | 7.73% | 21.27% | 14.74% | 23.62% | 48.48% | 23.51% | 23.56% |
| Return on Assets (ROA) | 4.99% | 4.17% | 3.67% | 2.12% | 5.76% | 4.2% | 6.61% | 12.58% | 6.12% | 6.4% |
| Equity / Assets | 30.09% | 29.65% | 28.96% | 25.98% | 28.07% | 28.84% | 27.27% | 24.7% | 27.29% | 27.04% |
| Book Value / Share | 9.33 | 9.27 | 9.59 | 9 | 11 | 12.52 | 13.45 | 12.85 | 15.34 | 16.46 |
| Debt / Equity | 0.18x | 0.18x | 0.17x | 0.18x | 0.15x | 0.13x | 0.16x | 0.34x | 0.14x | 0.07x |
| Revenue Growth | 2.49% | 2.68% | -2.09% | 2.44% | 22.7% | -1.88% | 19.83% | 43.47% | -10.95% | 17.09% |
| 2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Casualty | 324.02M | 454.84M | 478.6M | 523.47M | 558.46M | 569.52M | 633.64M | 711.83M | 758.35M | 852.84M |
| Casualty Growth | - | 40.37% | 5.22% | 9.37% | 6.68% | 1.98% | 11.26% | 12.34% | 6.53% | 12.46% |
| Property Insurance | - | 152.17M | 138.35M | 149.26M | 164.02M | 183.72M | 231.84M | 307.89M | 401.53M | 531.38M |
| Property Insurance Growth | - | - | -9.08% | 7.89% | 9.89% | 12.01% | 26.19% | 32.80% | 30.42% | 32.34% |
| Surety Insurance | - | 121.6M | 120.99M | 118.63M | 116.63M | 112.51M | 115.43M | 124.72M | 134.43M | 142.19M |
| Surety Insurance Growth | - | - | -0.50% | -1.95% | -1.69% | -3.54% | 2.60% | 8.05% | 7.79% | 5.77% |
| Property Insurance Product Line | 200.14M | - | - | - | - | - | - | - | - | - |
| Property Insurance Product Line Growth | - | - | - | - | - | - | - | - | - | - |
| Surety Product Line | 106.64M | - | - | - | - | - | - | - | - | - |
| Surety Product Line Growth | - | - | - | - | - | - | - | - | - | - |
RLI Corp. (RLI) has a price-to-earnings (P/E) ratio of 15.9x. This is roughly in line with market averages.
RLI Corp. (RLI) grew revenue by 17.1% over the past year. This is strong growth.
Yes, RLI Corp. (RLI) is profitable, generating $353.0M in net income for fiscal year 2024 (19.5% net margin).
RLI Corp. (RLI) does not currently pay a meaningful dividend. The company may be reinvesting profits for growth.
RLI Corp. (RLI) has a return on equity (ROE) of 23.6%. This is excellent, indicating efficient use of shareholder capital.
RLI Corp. (RLI) has a combined ratio of 75.8%. A ratio below 100% indicates underwriting profitability.